(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PCAS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

PCAS

ST13

US500000079187184

Classe

1, 4, 5, 42

Pedido

79187184

Registro

5211290

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

44

Atualização mais recente

14/09/2024

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 4, 5, 42

Data de depósito

28/01/2016

Data de registro

30/05/2017

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

15/12/2023

Última transação

15/12/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

99

Localização do titular

FR

Examinador

SMITH, REBECCA

Unidade examinadora

M10

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of a logotype representing a sequence of stylized DNA (symbolizing the life sciences) central axis composed of two dark blue quadrilaterals (symbolizing chemical structures) on either side of a larger transverse, light blue shape with broken lines. To the right of this logotype are the stylized letters "PCAS" in light blue.

Titulares e representantes

Titulares

PCAS
P. S. (pessoa física)

Representantes

MAURICE B. PILOSOF MAURICE B. PILOSOF, ESQ

Classificação técnica

Classes Nice

Classe 1Classe 4Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical products for use in industrysciencephotographyas well as in agriculturehorticulture and forestry; chemical preparations for solderingadhesive substances for industrial use; unprocessed artificial resinsunprocessed plastics; chemical reagents other than for medical or veterinary use

Classe 4

Industrial oils and greaseslubricants

Classe 5

Pharmaceuticalveterinary and sanitary products for medical purposessynthesis intermediates and active ingredients used in the manufacture of medicinalactive pharmaceutical ingredients (APIs)additives and chemical intermediatesantimicrobial preparations for preventing bacteria; pharmaceutical and medicinal preparations and substancesbacteriostatsantibioticsmedicinal preparations for the treatment of infectious diseasesmedicinal herbal extracts for medical purposes; Pharmaceutical productsActive Pharmaceutical ingredients (API's) for human and veterinary use; medicalbiologicalbiotechnologicalproteinvirologicalimmunologicalbacteriologicalchemicalenzymatic and products for medical and veterinary usemixed biological preparations for the prevention and treatment of infectious diseasescomplex molecules for life science and innovative technologiesbacteriological preparationschemical reagents; diagnostic preparations for medicalpharmaceutical and veterinary use; cellmicroorganism or virus cultures for medical and veterinary use; adjuvants for medical or veterinary use; antibioticspharmaceutical preparations for medical and veterinary usenucleic acidsproteinsrecombinant proteinspeptidespeptide antigensblood serumfor medicalpharmaceutical and veterinary use; biological products and preparations for medical usemedicinediagnostic reagents made from humananimal and microorganismfor the preventiondiagnosis or treatment of diseases and cellular veterinary products and preparationsfor use in biotechnologyparticularly for production of recombinant proteinsmonoclonal antibodiesfor biomedical diagnosticprophylactictherapeutic and clinical applicationexcipients; proteins arrays for medical or veterinary use; micro-organisms for medical usebacteriaalgaeincluding cell linescell cultures and cell expression systems from mammals used for biomolecule production

Classe 42

Scientific research; industrial research in the field of chemistrybiochemistryenzymologybiologymicrobiologycell biologypharmaceuticalsbiotechnology; research and development of new products for others; biological research; technical research in the field of chemistrybiochemistryenzymologybiologymicrobiologycell biologypharmaceuticalsbiotechnology and technical research for others relating to medical devices and pharmaceuticals in the field of veterinary

Publicações

Histórico de despachos e eventos da marca no USPTO.

44 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

14/09/2024

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

28/08/2024

INPC

INVALIDATION PROCESSED

28/08/2024

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

16/08/2024

C71T

CANCELLED SECTION 71

15/12/2023

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

30/05/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

28/10/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/09/2017

FIMP

FINAL DISPOSITION PROCESSED

07/09/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/08/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/08/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

30/05/2017

GPNX

NOTIFICATION PROCESSED BY IB

08/04/2017

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

23/03/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/03/2017

PUBO

PUBLISHED FOR OPPOSITION

14/03/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

22/02/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

22/02/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

22/02/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/02/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

24/01/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

24/01/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

24/01/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

24/01/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

24/01/2017

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

23/01/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

17/01/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

17/01/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

17/01/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

17/01/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

17/01/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

14/01/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

14/01/2017

ALIE

ASSIGNED TO LIE

13/01/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

14/12/2016

RFNT

REFUSAL PROCESSED BY IB

02/07/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

15/06/2016

RFRR

REFUSAL PROCESSED BY MPU

15/06/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

15/06/2016

CNRT

NON-FINAL ACTION WRITTEN

14/06/2016

MAFR

APPLICATION FILING RECEIPT MAILED

14/06/2016

DOCK

ASSIGNED TO EXAMINER

08/06/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/06/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/06/2016

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PCAS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.